Across TCGA pan-cancer cohorts, LINC02620 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC02620’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02620 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02620 is over-expressed in tumor, although a few such as KIRC and KICH show the opposite, repressed pattern.

KIRC, BRCA, and KICH are the cancer types where LINC02620 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02620 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	−0.030	<.001	7	view →
BRCA	All	III,IV	+1.484	<.001	6	view →
KICH	All	All	−0.039	.008	4	view →
UCEC	All	All	+0.624	.003	2	view →
KIRP	All	All	−0.047	.013	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: LINC02620 RNA expression & survival · all LINC02620 data types